← Back to Search

Habit Reversal Training for Tourette Syndrome

N/A
Waitlist Available
Led By Joseph F McGuire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week after completion of hrt
Awards & highlights

Study Summary

This trial looks at the treatment of tics in adults with Tourette Syndrome, and how effective different methods are.

Eligible Conditions
  • Tourette Syndrome
  • Tic Disorders
  • Habit Reversal Training
  • Tics
  • Comprehensive Behavioral Intervention for Tics (CBIT)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week after completion of hrt
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week after completion of hrt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS)
Secondary outcome measures
Tic disorder

Trial Design

1Treatment groups
Experimental Treatment
Group I: Habit Reversal TrainingExperimental Treatment1 Intervention
Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics. It will be delivered over 8 hours of treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Habit Reversal Training
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,256 Previous Clinical Trials
14,820,061 Total Patients Enrolled
7 Trials studying Tourette Syndrome
175 Patients Enrolled for Tourette Syndrome
Joseph F McGuire, PhDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Tourette Syndrome
20 Patients Enrolled for Tourette Syndrome

Media Library

Habit Reversal Training Clinical Trial Eligibility Overview. Trial Name: NCT04498364 — N/A
Tourette Syndrome Research Study Groups: Habit Reversal Training
Tourette Syndrome Clinical Trial 2023: Habit Reversal Training Highlights & Side Effects. Trial Name: NCT04498364 — N/A
Habit Reversal Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04498364 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are partaking in this research project?

"Affirmative, according to clinicaltrials.gov this research is presently in search of eligible candidates. It was first launched on September 18th 2020 and has had its parameters modified as recently as September 7th 2022 with the goal being 50 participants from one site."

Answered by AI

Is it currently possible to enroll in this investigation?

"Affirmative. The information hosted on clinicaltrials.gov states that this research endeavour, which was originally advertised on September 18th 2020, is currently recruiting participants. Approximately 50 patients need to be sourced from 1 medical facility."

Answered by AI

Does the trial invite participation from those over two decades of age?

"According to the prerequisites for joining this clinical trial, individuals must possess a minimum age of 18 and not exceed 75 years old."

Answered by AI

For whom is this trial medically suitable?

"This research study is looking for 50 individuals with tic-related conditions aged 18 to 75. To be eligible, they must not have had more than 4 prior HRT sessions and remain on a consistent dose of psychiatric medication for 8 weeks before taking part. They also need to demonstrate moderate severity of symptoms as measured by the YGTSS Total Tic Score (or >9 if only exhibiting motor or vocal tics)."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
How old are they?
18 - 65
What site did they apply to?
Johns Hopkins University School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Johns Hopkins University School of Medicine: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Extinction Learning in Adults With Tourette Syndrome
2020. "Extinction Learning in Adults With Tourette Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04498364.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top